- DocumentOSIMERTINIB COST EFFECTIVENESS fphar-13-920479uploaded byBeryl Ong
- DocumentSynthesizing study results in a systematic reviewuploaded byBeryl Ong
- DocumentRoche_Cancer_White_paper.pdfuploaded byBeryl Ong
- DocumentTremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma HIMALAYA NEJM 2022uploaded byBeryl Ong
- DocumentThe Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombosisuploaded byBeryl Ong
- DocumentFGD on Biologics AR (1)uploaded byBeryl Ong
- DocumentICONS BROCHUREuploaded byBeryl Ong
- DocumentBevacizumab Product Presentation Moduleuploaded byBeryl Ong
- DocumentMYL‑1402O A Bevacizumab Biosimilaruploaded byBeryl Ong
- DocumentImproving Access to Cancer Treatmentsuploaded byBeryl Ong
- Documentthe economic organisation of a p.o.w. camp Radford_1945uploaded byBeryl Ong